TCM and COVID-somnia: The Treatment of Sleeping Difficulties Due to the Coronavirus Pandemic - Part 2: Clinical Application

£4.00
VAT Exempt
In stock
SKU
JCM127/56
Download
Reward Points With this product, you earn 4 loyalty points.
Insomnia is one of the most common sequelae of COVID-19. Sleep difficulties are also being reported by people worldwide whose lives have been affected by the fear and anxiety of living through the coronavirus pandemic and the social isolation resulting from government restrictions. This increase in insomnia has led neurologists who specialise in sleep disorders to coin the term ‘COVID-somnia’. This article presents the clinical application of the theoretical framework introduced in part one of this series (issue 126 of the Journal of Chinese Medicine, June 2021) through two detailed COVIDsomnia case studies.
More Information
Author Rob Helmer
JCM Issue JCM127/56
Write Your Own Review
You're reviewing:TCM and COVID-somnia: The Treatment of Sleeping Difficulties Due to the Coronavirus Pandemic - Part 2: Clinical Application
Your Rating

* Orders shipped outside of Europe are eligible for VAT relief and will not be charged VAT.